Claude discovers enzyme system similar to CRISPR, dubbed ART
agents anthropic claude
| Source: Mastodon | Original article
Anthropic's Claude AI identified a CRISPR‑like enzyme system, named ART, in phage DNA, which human scientists have experimentally confirmed.
Anthropic announced that a swarm of its Claude agents has uncovered a previously unknown enzyme system in bacteriophage DNA, which the company has dubbed array‑associated reverse transcriptases (ART). The discovery emerged from a 21‑hour computational campaign that deployed roughly 950 Claude agents to scan DNA and reverse‑transcriptase data, processing about 210 million tokens. Human researchers at Anthropic’s new Bay Area life‑sciences lab subsequently validated the findings in the laboratory, though the results have not yet been submitted for peer review.
The ART system is notable for its CRISPR‑like architecture: it combines a reverse‑transcriptase enzyme, a partner gene, and an array of evenly spaced DNA repeats that resemble the spacer sequences used by CRISPR immune systems. By surfacing this hidden defense mechanism, Claude demonstrates how large‑scale multi‑agent AI can accelerate the identification of biologically relevant patterns that would be difficult to detect through manual analysis alone.
The breakthrough matters for several reasons. First, it expands the catalog of phage‑encoded tools that could be repurposed for gene‑editing or synthetic‑biology applications, potentially offering alternatives to existing CRISPR platforms. Second, it showcases a concrete, laboratory‑verified example of AI‑driven discovery, reinforcing Anthropic’s claim that its models can move beyond code generation into tangible scientific output. Finally, the rapid turnaround—less than a day of compute time—highlights a new efficiency frontier for life‑science research.
What to watch next includes the peer‑review process that will confirm the functional role of ART, and any follow‑up studies that explore its utility in biotechnology. Anthropic’s life‑sciences lab is likely to leverage the same multi‑agent approach on other genomic datasets, suggesting a pipeline of AI‑assisted discoveries. As we reported on 25 September, Claude’s multi‑agent system already identified a novel enzyme system in phage DNA; this latest announcement refines that finding and underscores the growing relevance of AI in the life‑sciences arena.
Sources
Back to AIPULSEN